- Home
- AGIO vs DAVA Comparison
AGIO vs DAVA Comparison
Compare AGIO & DAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGIO
- DAVA
- Stock Information
- Founded
- AGIO 2007
- DAVA 2000
- Country
- AGIO United States
- DAVA United Kingdom
- Employees
- AGIO N/A
- DAVA N/A
- Industry
- AGIO Biotechnology: Pharmaceutical Preparations
- DAVA EDP Services
- Sector
- AGIO Health Care
- DAVA Technology
- Exchange
- AGIO Nasdaq
- DAVA Nasdaq
- Market Cap
- AGIO 2.0B
- DAVA 1.8B
- IPO Year
- AGIO 2013
- DAVA 2018
- Fundamental
- Price
- AGIO $33.23
- DAVA $31.42
- Analyst Decision
- AGIO Buy
- DAVA Buy
- Analyst Count
- AGIO 7
- DAVA 12
- Target Price
- AGIO $56.33
- DAVA $40.68
- AVG Volume (30 Days)
- AGIO 975.9K
- DAVA 343.2K
- Earning Date
- AGIO 02-13-2025
- DAVA 02-27-2025
- Dividend Yield
- AGIO N/A
- DAVA N/A
- EPS Growth
- AGIO N/A
- DAVA N/A
- EPS
- AGIO 11.80
- DAVA 0.16
- Revenue
- AGIO $32,871,000.00
- DAVA $1,001,724,970.00
- Revenue This Year
- AGIO $33.41
- DAVA $10.78
- Revenue Next Year
- AGIO $172.14
- DAVA $10.46
- P/E Ratio
- AGIO $2.78
- DAVA $197.00
- Revenue Growth
- AGIO 36.79
- DAVA N/A
- 52 Week Low
- AGIO $21.18
- DAVA $23.28
- 52 Week High
- AGIO $62.58
- DAVA $80.26
- Technical
- Relative Strength Index (RSI)
- AGIO 36.88
- DAVA 58.27
- Support Level
- AGIO $31.39
- DAVA $31.00
- Resistance Level
- AGIO $35.03
- DAVA $32.03
- Average True Range (ATR)
- AGIO 1.71
- DAVA 1.11
- MACD
- AGIO 0.54
- DAVA -0.09
- Stochastic Oscillator
- AGIO 39.91
- DAVA 40.69
About AGIO Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.
About DAVA Endava plc (each representing one)
Endava is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2006 in the U.K. and it continues to generate the majority of revenue in the U.K. and Europe. Endava's client base is concentrated in the payments and financial services, technology, media, and telecom industries.